Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Asset Writedowns and Impairment (2021 - 2025)

Historic Asset Writedowns and Impairment for Health Catalyst (HCAT) over the last 5 years, with Q3 2025 value amounting to $6.9 million.

  • Health Catalyst's Asset Writedowns and Impairment changed N/A to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 9166.67%. This contributed to the annual value of $2.2 million for FY2024, which is 4609.16% down from last year.
  • Latest data reveals that Health Catalyst reported Asset Writedowns and Impairment of $6.9 million as of Q3 2025.
  • In the past 5 years, Health Catalyst's Asset Writedowns and Impairment registered a high of $6.9 million during Q3 2025, and its lowest value of $98000.0 during Q4 2022.
  • In the last 5 years, Health Catalyst's Asset Writedowns and Impairment had a median value of $2.0 million in 2023 and averaged $2.6 million.
  • In the last 5 years, Health Catalyst's Asset Writedowns and Impairment surged by 10555.56% in 2022 and then skyrocketed by 132857.14% in 2023.
  • Health Catalyst's Asset Writedowns and Impairment (Quarter) stood at $1.8 million in 2021, then crashed by 94.56% to $98000.0 in 2022, then surged by 1328.57% to $1.4 million in 2023, then soared by 57.14% to $2.2 million in 2024, then skyrocketed by 213.64% to $6.9 million in 2025.
  • Its Asset Writedowns and Impairment was $6.9 million in Q3 2025, compared to $2.2 million in Q1 2024 and $1.4 million in Q4 2023.